Trial · NCT07883174
Motion Capture in Box and Bloks Test
NCT07883174, Completed, IRCCS San Raffaele Roma
3 sourcestrials-2026-11-12-0.5.0
Download JSON
Cite this record
ConductScience Library. Motion Capture in Box and Bloks Test. Trials, record NCT07883174. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07883174
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Motion Capture in Box and Bloks Test
- NCT number
- NCT07883174
- Status
- Completed
- Enrollment
- 105 participants, actual
- Lead sponsor
- IRCCS San Raffaele Roma
- Conditions
- Healthy, Parkinson Disease, Stroke, Upper Extremity Paresis, Adults
- Interventions
- Inertial Measurement Unit and Box and Block test
- First posted
- 2026-10-20
- Last updated
- 2026-10-20
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | IMU-based targeted Box and Block Test (t-BBT) | Baseline | Instrumental assessment of manual dexterity will be conducted using a sensorized and targeted BBT (tBBT): 16 wooden blocks, 2.5cm3 in size, are placed on a 4x4 grid in the container closest to the limb to be assessed. The subject must grasp one block at a time with a pre-established order (numbering in figure 2), transfer it over the dividing wall and release it on the corresponding position of a 4x4 grid present in the other container, as quickly as possible. Acquisition duration: time necessary to complete the exercise. After 2 minutes the acquisition is however interrupted. |
| Other | Standard BBT | Baseline | The Box and Block Test (BBT) measures unilateral gross manual dexterity. It is a quick, simple and inexpensive test. It can be used with a wide range of populations, including clients with stroke. The BBT is composed of a wooden box divided in two compartments by a partition and 150 blocks. The BBT administration consists of asking the client to move, one by one, the maximum number of blocks from one compartment of a box to another of equal size, within 60 seconds. The box should be oriented lengthwise and placed at the client's midline, with the compartment holding the blocks oriented towards the hand being tested. In order to practice and register baseline scores, the test should begin with the unaffected upper limb. |
| Other | Passive Range of Motion (ROM) | Baseline | Range Of Motion (ROM) is the arc of motion available at a single joint or series of joints. It is the angle through which the joint moves from the anatomical position to the extreme limit of its motion in a particular direction. In essence, it is the extent to which a part of the body can be moved around a joint or a fixed point. |
| Other | Hoehn & Yahr (H&Y) | Baseline | The scale has been used for the staging of the functional disability associated with Parkinson's disease. It helps in describing the progression of the disease through various stages, thus allowing us to measure the severity of the case. 1 Unilateral involvement only usually with minimal or no functional disability Unilateral involvement only 1.5 - Unilateral and axial involvement 2 Bilateral or midline involvement without impairment of balance Bilateral involvement without impairment of balance 2.5 - Mild bilateral disease with recovery on pull test 3 Bilateral disease: mild to moderate disability with impaired postural reflexes; physically independent Mild to moderate bilateral disease; some postural instability; physically independent 4 Severely disabling disease; still able to walk or stand unassisted Severe disability; still able to walk or stand unassisted 5 Confinement to bed or wheelchair unless aided Wheelchair bound or bedridden unless aided |
| Other | Unified Parkinson's Disease Rating Scale (UPDRS): UPDRS (2) e (3) | Baseline | Unified Parkinson's Disease Rating Scale (UPDRS) is a rating tool used to gauge the the severity and progression of Parkinson's disease in patients. Unified Parkinson's Disease Rating Scale (UPDRS) is a rating tool used to gauge the the severity and progression of Parkinson's disease in patients\[1\]. The UPDRS scale consists of the following six segments: 1) Mentation, Behavior, and Mood, 2) ADL, 3) Motor sections, 4) Complications of Therapy (in the past week) 5) Modified Hoehn and Yahr Scale, and 6) Schwab and England ADL scale. The first four segments are made up of 42 items grouped into four subscales. The UPDRS was developed in 1987 as a gold standard by neurologists for monitoring the response to medications used to decrease the signs and symptoms of Parkinson's. |
| Other | Freezing Of Gait Questionaire (FOGQ) | Baseline | The FOGQ assesses Freezing of Gait (FOG) severity unrelated to falls in patients with Parkinson's Disease (PD), FOG frequency, disturbances in gait, and relationship to clinical features conceptually associated with gait and motor aspects (e.g., turning). The NFOG-Q doesn't require any equipment and is simple to administer. When rating the frequency of FOG over the previous month, patients independently complete the questionnaire, reporting both ON and OFF medication states. Responses to all but item 1 are added up to determine the final score, which ranges from 0 to 28. Higher ratings indicate greater impact and intensity of freezing episodes. Patients who respond negatively to item 1, which functions as a screening question, may be categorised as non-freezers. |
| Other | Frenchay-Activities-Index (FAI) | Baseline | The aim is to record activities which require some initiative from the patient. It is important to concentrate upon the patient's actual frequency of activity over the recent past, not distant past performance nor potential performance. One activity can only score on one item. The frequency with which each item or activity is undertaken over the past 3-6 months (depending on the nature of the activity) is assigned a score of 1 - 4 where a score of 1 is indicative of the lowest level of activity. The scale provides a summed score from 15 - 60. |
| Other | Fugl-Meyer Assessment Upper Limb (FM-UL) | Baseline | The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index. it is designed to assess motor functioning, balance, sensation and joint functioning in patients with post-stroke hemiplegia. It is divided in Upper and Lower limb assesment. It is applied clinically and in research to determine disease severity, describe motor recovery, and to plan and assess treatment. Scoring is based on direct observation of performance. Scale items are scored on the basis of ability to complete the item using a 3-point ordinal scale where 0=cannot perform, 1=performs partially and 2=performs fully. The total possible scale score for the Fugl-Meyer Assesment for Upper Limb is 126 points.. Points are divided among the domains as follows: Motor score: ranges from 0 (hemiplegia) to 66 points (normal motor performance); Sensation: ranges from 0 to 12 point; Joint range of motion: ranges from 0 to 24 point; Pain: from 0 to 24 point. |
| Other | Modified Ashworth Scale (MAS) | Baseline | The Modified Ashworth Scale (MAS) is used to assess spasticity.The Modified Ashworth Scale (MAS) is used to assess spasticity. The test is performed by extending the patients limb's first from a position of maximal possible flexion to maximal possible extension (the point at which the first soft resistance is met). Afterwards, the modified Ashworth scale is assessed while moving from extension to flexion. Joint angles are measured in degrees. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07883174
GET https://conductscience.org/api/trials/v1/NCT07883174/registered